Vault-13

Deep Track Capital, LP

GREENWICH, CT · CIK 1856083 · 13F filing filed 2025-08-14

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$3.1bn reported value +0.7% vs Q1 2025
65positions
52.6%in top 10
7 new 18 added 20 reduced 11 sold out vs Q1 2025

Options: 0 call positions (— notional), 1 put positions ($7.7m notional) – listed below, not included above.

Holdings, Q2 2025

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 GUARDANT HEALTH INC COM GH GH 4,250,000 $221.2m7.11% 7.11% ReducedShares held: Q3 2024 6.0m, Q4 2024 6.4m, Q1 2025 5.4m, Q2 2025 4.2m -1.2m -1,193,721 -21.9%
2 IONIS PHARMACEUTICALS INC COM IONS IONS 4,891,544 $193.3m6.21% 6.21% AddedShares held: Q3 2024 2.2m, Q4 2024 1.9m, Q1 2025 4.6m, Q2 2025 4.9m +327.3k +327,337 7.2%
3 PROTAGONIST THERAPEUTICS INC COM PTGX PTGX 3,245,899 $179.4m5.77% 5.77% AddedShares held: Q3 2024 0, Q4 2024 1.0m, Q1 2025 3.0m, Q2 2025 3.2m +245.9k +245,899 8.2%
4 DYNAVAX TECHNOLOGIES CORP COM NEW DVAX DVAX 17,791,486 $176.5m5.67% 5.67% UnchangedShares held: Q3 2024 12.5m, Q4 2024 17.8m, Q1 2025 17.8m, Q2 2025 17.8m
5 INSMED INC COM PAR $.01 INSM INSM 1,750,000 $176.1m5.66% 5.66% AddedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 254.8k, Q2 2025 1.8m +1.5m +1,495,249 587.0%
6 AKERO THERAPEUTICS INC COM AKRO AKRO 3,042,598 $162.4m5.22% 5.22% ReducedShares held: Q3 2024 689.8k, Q4 2024 1.5m, Q1 2025 3.2m, Q2 2025 3.0m -167.7k -167,672 -5.2%
7 IMMUNOVANT INC COM IMVT IMVT 9,500,000 $152.0m4.89% 4.89% UnchangedShares held: Q3 2024 4.3m, Q4 2024 6.0m, Q1 2025 9.5m, Q2 2025 9.5m
8 OCULAR THERAPEUTIX INC COM OCUL OCUL 14,294,420 $132.7m4.26% 4.26% UnchangedShares held: Q3 2024 12.7m, Q4 2024 12.8m, Q1 2025 14.3m, Q2 2025 14.3m
9 APELLIS PHARMACEUTICALS INC COM APLS APLS 7,000,000 $121.2m3.90% 3.90% AddedShares held: Q3 2024 4.4m, Q4 2024 4.3m, Q1 2025 5.0m, Q2 2025 7.0m +2.0m +2,000,000 40.0%
10 CYTOKINETICS INC COM NEW CYTK CYTK 3,650,000 $120.6m3.88% 3.88% AddedShares held: Q3 2024 629.9k, Q4 2024 2.5m, Q1 2025 3.1m, Q2 2025 3.6m +576.1k +576,147 18.7%
11 STRUCTURE THERAPEUTICS INC SPONSORED ADS GPCR GPCR 5,133,917 $106.5m3.42% 3.42% AddedShares held: Q3 2024 1.2m, Q4 2024 2.8m, Q1 2025 4.1m, Q2 2025 5.1m +1.0m +1,033,917 25.2%
12 89BIO INC COM ETNB ETNB 9,500,000 $93.3m3.00% 3.00% AddedShares held: Q3 2024 2.8m, Q4 2024 6.5m, Q1 2025 9.3m, Q2 2025 9.5m +183.7k +183,667 2.0%
13 AXSOME THERAPEUTICS INC COM AXSM AXSM 801,371 $83.7m2.69% 2.69% NewShares held: Q3 2024 857.2k, Q4 2024 0, Q1 2025 0, Q2 2025 801.4k
14 VIRIDIAN THERAPEUTICS INC COM VRDN VRDN 5,380,449 $75.2m2.42% 2.42% UnchangedShares held: Q3 2024 3.8m, Q4 2024 4.5m, Q1 2025 5.4m, Q2 2025 5.4m
15 TARSUS PHARMACEUTICALS INC COM TARS TARS 1,750,000 $70.9m2.28% 2.28% AddedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 1.5m, Q2 2025 1.8m +265.7k +265,734 17.9%
16 VAXCYTE INC COM PCVX PCVX 2,150,000 $69.9m2.25% 2.25% AddedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 750.0k, Q2 2025 2.1m +1.4m +1,400,000 186.7%
17 NURIX THERAPEUTICS INC COM NRIX NRIX 6,064,910 $69.1m2.22% 2.22% AddedShares held: Q3 2024 3.9m, Q4 2024 3.0m, Q1 2025 5.5m, Q2 2025 6.1m +564.9k +564,910 10.3%
18 GERON CORP COM GERN GERN 43,000,000 $60.6m1.95% 1.95% AddedShares held: Q3 2024 7.6m, Q4 2024 4.0m, Q1 2025 38.2m, Q2 2025 43.0m +4.8m +4,823,749 12.6%
19 IMMUNOCORE HLDGS PLC ADS IMCR IMCR 1,800,000 $56.5m1.82% 1.82% AddedShares held: Q3 2024 0, Q4 2024 519.4k, Q1 2025 1.4m, Q2 2025 1.8m +388.6k +388,598 27.5%
20 ULTRAGENYX PHARMACEUTICAL IN COM RARE RARE 1,350,000 $49.1m1.58% 1.58% UnchangedShares held: Q3 2024 0, Q4 2024 653.5k, Q1 2025 1.4m, Q2 2025 1.4m
21 MAZE THERAPEUTICS INC COM MAZE MAZE 3,948,910 $48.5m1.56% 1.56% AddedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 3.3m, Q2 2025 3.9m +679.8k +679,784 20.8%
22 ANI PHARMACEUTICALS INC COM ANIP ANIP 700,000 $45.7m1.47% 1.47% UnchangedShares held: Q3 2024 504.8k, Q4 2024 649.0k, Q1 2025 700.0k, Q2 2025 700.0k
23 XENON PHARMACEUTICALS INC COM XENE XENE 1,350,000 $42.3m1.36% 1.36% AddedShares held: Q3 2024 0, Q4 2024 169.1k, Q1 2025 1.0m, Q2 2025 1.4m +350.0k +350,000 35.0%
24 DIANTHUS THERAPEUTICS INC COM DNTH DNTH 2,233,148 $41.6m1.34% 1.34% ReducedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 2.4m, Q2 2025 2.2m -124.6k -124,554 -5.3%
25 CELLDEX THERAPEUTICS INC NEW COM NEW CLDX CLDX 2,000,000 $40.7m1.31% 1.31% UnchangedShares held: Q3 2024 0, Q4 2024 1.5m, Q1 2025 2.0m, Q2 2025 2.0m
26 BRIDGEBIO PHARMA INC COM BBIO BBIO 900,000 $38.9m1.25% 1.25% ReducedShares held: Q3 2024 0, Q4 2024 819.2k, Q1 2025 2.8m, Q2 2025 900.0k -1.9m -1,900,000 -67.9%
27 AUTOLUS THERAPEUTICS PLC SPON ADS AUTL AUTL 16,852,147 $38.4m1.24% 1.24% ReducedShares held: Q3 2024 15.3m, Q4 2024 14.2m, Q1 2025 17.8m, Q2 2025 16.9m -997.3k -997,335 -5.6%
28 METSERA INC COM COM 1,094,408 $31.1m1.00% 1.00% UnchangedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 1.1m, Q2 2025 1.1m
29 TERNS PHARMACEUTICALS INC COM COM 7,495,000 $28.0m0.90% 0.90% AddedShares held: Q3 2024 5.6m, Q4 2024 5.6m, Q1 2025 5.6m, Q2 2025 7.5m +1.9m +1,918,442 34.4%
30 TECTONIC THERAPEUTIC INC COM TECX TECX 1,401,938 $27.9m0.90% 0.90% UnchangedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 1.4m, Q2 2025 1.4m
31 ABIVAX SA SPONSORED ADS ABVX ABVX 3,480,144 $26.6m0.86% 0.86% ReducedShares held: Q3 2024 3.6m, Q4 2024 3.6m, Q1 2025 3.6m, Q2 2025 3.5m -99.1k -99,065 -2.8%
32 JADE BIOSCIENCES INC COM NEW JBIO JBIO 2,509,301 $25.1m0.81% 0.81% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 2.5m
33 MBX BIOSCIENCES INC COM MBX MBX 2,188,592 $25.0m0.80% 0.80% ReducedShares held: Q3 2024 3.0m, Q4 2024 3.0m, Q1 2025 3.0m, Q2 2025 2.2m -830.3k -830,343 -27.5%
34 COMPASS PATHWAYS PLC SPONSORED ADS CMPS CMPS 8,831,007 $24.7m0.79% 0.79% ReducedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 8.9m, Q2 2025 8.8m -28.6k -28,641 -0.3%
35 GH RESEARCH PLC ORDINARY SHARES GHRS GHRS 2,000,000 $24.4m0.78% 0.78% UnchangedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 2.0m, Q2 2025 2.0m
36 BICARA THERAPEUTICS INC COM BCAX BCAX 2,426,657 $22.5m0.72% 0.72% AddedShares held: Q3 2024 796.9k, Q4 2024 2.0m, Q1 2025 2.0m, Q2 2025 2.4m +426.7k +426,657 21.3%
37 ORUKA THERAPEUTICS INC COM ORKA ORKA 1,918,798 $21.5m0.69% 0.69% AddedShares held: Q3 2024 1.2m, Q4 2024 750.0k, Q1 2025 1.4m, Q2 2025 1.9m +474.1k +474,089 32.8%
38 ENGENE HOLDINGS INC COM COM 4,557,575 $16.6m0.53% 0.53% UnchangedShares held: Q3 2024 2.6m, Q4 2024 4.6m, Q1 2025 4.6m, Q2 2025 4.6m
39 MIND MEDICINE MINDMED INC COM NEW COM NEW 2,500,000 $16.2m0.52% 0.52% UnchangedShares held: Q3 2024 7.1m, Q4 2024 2.8m, Q1 2025 2.5m, Q2 2025 2.5m
40 UPSTREAM BIO INC COM UPB UPB 1,442,767 $15.8m0.51% 0.51% ReducedShares held: Q3 2024 0, Q4 2024 1.0m, Q1 2025 2.3m, Q2 2025 1.4m -856.8k -856,800 -37.3%
41 OLEMA PHARMACEUTICALS INC COM OLMA OLMA 3,442,833 $14.7m0.47% 0.47% UnchangedShares held: Q3 2024 4.0m, Q4 2024 3.4m, Q1 2025 3.4m, Q2 2025 3.4m
42 MERUS N V COM MRUS MRUS 275,000 $14.5m0.47% 0.47% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 275.0k
43 CYBIN INC COM NEW COM NEW 1,529,987 $12.8m0.41% 0.41% UnchangedShares held: Q3 2024 1.5m, Q4 2024 1.5m, Q1 2025 1.5m, Q2 2025 1.5m
44 CIDARA THERAPEUTICS INC COM NEW CDTX CDTX 250,000 $12.2m0.39% 0.39% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 250.0k
45 BICYCLE THERAPEUTICS PLC SPONSORED ADS BCYC BCYC 1,203,244 $8.4m0.27% 0.27% AddedShares held: Q3 2024 3.5m, Q4 2024 1.3m, Q1 2025 767.0k, Q2 2025 1.2m +436.2k +436,228 56.9%
46 CRESCENT BIOPHARMA INC. COM CBIO CBIO 453,686 $7.3m0.24% 0.24% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 453.7k
47 CENTESSA PHARMACEUTICALS PLC SPONSORED ADS SPONSORED ADS 500,000 $6.6m0.21% 0.21% NewShares held: Q3 2024 1.4m, Q4 2024 1.4m, Q1 2025 0, Q2 2025 500.0k
48 NOVAVAX INC COM NEW NVAX NVAX 998,542 $6.3m0.20% 0.20% ReducedShares held: Q3 2024 0, Q4 2024 2.0m, Q1 2025 1.5m, Q2 2025 998.5k -519.6k -519,640 -34.2%
49 INVIVYD INC COM IVVD IVVD 8,585,980 $6.1m0.20% 0.20% ReducedShares held: Q3 2024 11.0m, Q4 2024 10.7m, Q1 2025 9.7m, Q2 2025 8.6m -1.1m -1,136,274 -11.7%
50 RAPT THERAPEUTICS INC COM NEW RAPT RAPT 751,422 $6.0m0.19% 0.19% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 751.4k
51 CONTEXT THERAPEUTICS INC COM CNTX CNTX 7,419,355 $4.9m0.16% 0.16% UnchangedShares held: Q3 2024 7.4m, Q4 2024 7.4m, Q1 2025 7.4m, Q2 2025 7.4m
52 PLIANT THERAPEUTICS INC COM PLRX PLRX 3,947,807 $4.6m0.15% 0.15% ReducedShares held: Q3 2024 6.0m, Q4 2024 6.0m, Q1 2025 5.4m, Q2 2025 3.9m -1.5m -1,451,874 -26.9%
53 SAREPTA THERAPEUTICS INC COM SRPT SRPT 259,800 $4.4m0.14% 0.14% ReducedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 899.7k, Q2 2025 259.8k -639.9k -639,931 -71.1%
54 XENCOR INC COM XNCR XNCR 549,439 $4.3m0.14% 0.14% UnchangedShares held: Q3 2024 800.0k, Q4 2024 500.0k, Q1 2025 549.4k, Q2 2025 549.4k
55 INOVIO PHARMACEUTICALS INC COM SHS INO INO 1,981,370 $4.0m0.13% 0.13% ReducedShares held: Q3 2024 1.8m, Q4 2024 3.1m, Q1 2025 3.1m, Q2 2025 2.0m -1.1m -1,137,792 -36.5%
56 KORRO BIO INC COM KRRO KRRO 277,966 $3.5m0.11% 0.11% ReducedShares held: Q3 2024 850.0k, Q4 2024 874.6k, Q1 2025 874.6k, Q2 2025 278.0k -596.6k -596,648 -68.2%
57 IKENA ONCOLOGY INC COM COM 2,515,513 $3.4m0.11% 0.11% UnchangedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 2.5m, Q2 2025 2.5m
58 SPYRE THERAPEUTICS INC COM NEW SYRE SYRE 219,015 $3.3m0.11% 0.11% UnchangedShares held: Q3 2024 1.0m, Q4 2024 219.0k, Q1 2025 219.0k, Q2 2025 219.0k
59 ALIGOS THERAPEUTICS INC COM NEW ALGS ALGS 444,110 $3.2m0.10% 0.10% UnchangedShares held: Q3 2024 244.1k, Q4 2024 244.1k, Q1 2025 444.1k, Q2 2025 444.1k
60 AVALO THERAPEUTICS INC COM NEW AVTX AVTX 567,103 $2.8m0.09% 0.09% ReducedShares held: Q3 2024 967.0k, Q4 2024 867.0k, Q1 2025 859.9k, Q2 2025 567.1k -292.8k -292,773 -34.0%
61 ZURA BIO LTD CLASS A ORD SHS ZURA ZURA 1,727,562 $1.8m0.06% 0.06% ReducedShares held: Q3 2024 3.3m, Q4 2024 3.3m, Q1 2025 3.3m, Q2 2025 1.7m -1.6m -1,556,221 -47.4%
62 CLIMB BIO INC COM CLYM CLYM 1,040,115 $1.3m0.04% 0.04% UnchangedShares held: Q3 2024 2.2m, Q4 2024 1.0m, Q1 2025 1.0m, Q2 2025 1.0m
63 SEPTERNA INC COM SEPN SEPN 121,716 $1.3m0.04% 0.04% ReducedShares held: Q3 2024 0, Q4 2024 1.9m, Q1 2025 1.9m, Q2 2025 121.7k -1.8m -1,791,213 -93.6%
64 RAPPORT THERAPEUTICS INC COM RAPP RAPP 98,237 $1.1m0.04% 0.04% ReducedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 457.6k, Q2 2025 98.2k -359.3k -359,319 -78.5%
65 ONKURE THERAPEUTICS INC COM CL A OKUR OKUR 180,510 $431.4k0.01% 0.01% ReducedShares held: Q3 2024 0, Q4 2024 524.0k, Q1 2025 524.0k, Q2 2025 180.5k -343.5k -343,479 -65.5%

Sold out since Q1 2025

SecurityTickerShares held beforeValue then
INTRA-CELLULAR THERAPIES INC ITCI ITCI 2,000,000 $263.8m2.0m shares
AMGEN INC AMGN AMGN 113,035 $35.2m113.0k shares
EDGEWISE THERAPEUTICS INC EWTX EWTX 1,400,000 $30.8m1.4m shares
DYNE THERAPEUTICS INC DYN DYN 2,000,000 $20.9m2.0m shares
GALAPAGOS NV LKFT LKFT 741,068 $18.6m741.1k shares
SAGE THERAPEUTICS INC SAGE SAGE 2,038,845 $16.2m2.0m shares
RAPT THERAPEUTICS INC 6,011,380 $7.3m6.0m shares
BEAM THERAPEUTICS INC BEAM BEAM 315,765 $6.2m315.8k shares
REGULUS THERAPEUTICS INC RGLS RGLS 3,262,564 $5.7m3.3m shares
ALLAKOS INC ALLKG ALLKG 7,232,701 $1.6m7.2m shares
NEUROGENE INC NGNE NGNE 116,660 $1.4m116.7k shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
SAREPTA THERAPEUTICS INC SRPT · Put SRPTPut 450,000 $7.7m450.0k shares New

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on. The largest 25 of 27.

CompanyTickerStakeChange ScheduleLast filed
LB PHARMACEUTICALS INC LBRX · 13D · filed 2026-02-10 LBRX 11.7%≈ $108.8m -3.2 pts 13D 2026-02-10
ALTIMMUNE INC ALT · 13G · filed 2026-04-30 ALT 10.0%≈ $59.0m new 13G 2026-04-30
PROMIS NEUROSCIENCES INC PMN · 13G · filed 2026-02-06 PMN 10.0%≈ $11.9m new 13G 2026-02-06
VERASTEM INC VSTM · 13G · filed 2025-11-21 VSTM 10.0%≈ $29.5m new 13G 2025-11-21
COMPASS PATHWAYS PLC CMPS · 13G · filed 2025-01-17 CMPS 10.0% new 13G 2025-01-17
RAPT THERAPEUTICS INC 13G · filed 2024-12-23 9.9% new 13G 2024-12-23
MOONLAKE IMMUNOTHERAPEUTICS MLTX · 13G · filed 2026-08-14 MLTX 9.7%≈ $155.7m +3.3 pts 13G 2026-08-14
OCULAR THERAPEUTIX INC OCUL · 13G · filed 2026-05-15 OCUL 9.5%≈ $204.7m +4.4 pts 13G 2026-05-15
MAZE THERAPEUTICS INC MAZE · 13G · filed 2025-08-14 MAZE 9.0%≈ $117.8m +2.1 pts 13G 2025-08-14
IMMUNIC INC 13G · filed 2026-03-04 8.7% new 13G 2026-03-04
ALECTOR INC ALEC · 13G · filed 2026-10-23 ALEC 8.6%≈ $21.3m new 13G 2026-10-23
TARSUS PHARMACEUTICALS INC TARS · 13G · filed 2026-05-15 TARS 8.5%≈ $226.6m +1.4 pts 13G 2026-05-15
X4 PHARMACEUTICALS INC XFOR · 13G · filed 2026-08-14 XFOR 8.3%≈ $37.6m -1.7 pts 13G 2026-08-14
CONTEXT THERAPEUTICS INC CNTX · 13G · filed 2025-05-15 CNTX 8.3%≈ $4.1m 13G 2025-05-15
HEMAB THERAPEUTICS HLDGS INC COAG · 13G · filed 2026-05-08 COAG 8.2%≈ $132.3m new 13G 2026-05-08
CORMEDIX INC CRMD · 13G · filed 2026-05-15 CRMD 7.9%≈ $49.3m +1.7 pts 13G 2026-05-15
NURIX THERAPEUTICS INC NRIX · 13G · filed 2026-08-14 NRIX 7.5%≈ $187.7m +1.3 pts 13G 2026-08-14
CENTURY THERAPEUTICS INC IPSC · 13G · filed 2026-01-15 IPSC 7.3%≈ $33.0m new 13G 2026-01-15
ACLARIS THERAPEUTICS INC ACRS · 13G · filed 2026-03-17 ACRS 7.0%≈ $49.4m new 13G 2026-03-17
AVALO THERAPEUTICS INC AVTX · 13G · filed 2026-08-14 AVTX 6.9%≈ $66.7m +1.1 pts 13G 2026-08-14
MIND MEDICINE MINDMED INC 13G · filed 2025-11-14 6.9% -1.3 pts 13G 2025-11-14
ENGENE HOLDINGS INC 13G · filed 2025-11-18 6.7% +2.3 pts 13G 2025-11-18
BICARA THERAPEUTICS INC BCAX · 13G · filed 2026-05-15 BCAX 6.2%≈ $120.6m +1.2 pts 13G 2026-05-15
ALUMIS INC ALMS · 13G · filed 2026-04-07 ALMS 6.0%≈ $207.2m new 13G 2026-04-07
STRUCTURE THERAPEUTICS INC GPCR · 13G · filed 2026-02-13 GPCR 6.0% -1.4 pts 13G 2026-02-13